Cardioprotective potential of antihypertensives

Related Experiment Videos

L Hansson1

  • 1Division of Geriatrics, University of Uppsala, Sweden.

American Journal of Hypertension
|October 1, 1995
PubMed

Insights

Lowering high blood pressure effectively prevents stroke. Newer therapies may offer better protection against coronary heart disease (CHD) in hypertensive patients compared to older treatments.

Area of Science:

  • Cardiology
  • Pharmacology
  • Public Health

Background:

  • Arterial hypertension treatment aims to reduce cardiovascular risks.
  • Pharmacological interventions significantly lower stroke incidence.
  • The impact of hypertension treatment on coronary heart disease (CHD) is less clear, potentially due to historical reliance on diuretics in major trials.

Purpose of the Study:

  • To review evidence on the effectiveness of hypertension treatment in preventing cardiovascular morbidity and mortality.
  • To explore the potential of newer pharmacological agents, such as angiotensin converting enzyme inhibitors, in preventing CHD in hypertensive individuals.

Main Methods:

  • Review of existing literature and intervention trial data.
  • Analysis of pharmacological interventions for arterial hypertension.
  • Comparison of therapeutic effects on stroke and coronary heart disease.

Main Results:

  • Established preventive effect of blood pressure lowering on stroke.
  • Less definitive evidence for CHD prevention with older therapies (e.g., diuretics).
  • Emerging evidence suggests newer therapies may be more effective for CHD prevention.

Conclusions:

  • Reducing blood pressure is crucial for preventing stroke in hypertensive patients.
  • Further research and clinical application of newer antihypertensive drugs are warranted for improved CHD prevention.

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Antihypertensive Drugs: Action of β1 Blockers01:17

Antihypertensive Drugs: Action of β1 Blockers

β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this, β1-blockers...
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...